TY - JOUR
T1 - Rare copy number variation in posttraumatic stress disorder
AU - Maihofer, Adam X
AU - Engchuan, Worrawat
AU - Huguet, Guillaume
AU - Klein, Marieke
AU - MacDonald, Jeffrey R
AU - Shanta, Omar
AU - Thiruvahindrapuram, Bhooma
AU - Jean-Louis, Martineau
AU - Saci, Zohra
AU - Jacquemont, Sebastien
AU - Scherer, Stephen W
AU - Ketema, Elizabeth
AU - Aiello, Allison E
AU - Amstadter, Ananda B
AU - Avdibegović, Esmina
AU - Babic, Dragan
AU - Baker, Dewleen G
AU - Bisson, Jonathan I
AU - Boks, Marco P
AU - Bolger, Elizabeth A
AU - Bryant, Richard A
AU - Bustamante, Angela C
AU - Caldas-de-Almeida, Jose Miguel
AU - Cardoso, Graça
AU - Deckert, Jurgen
AU - Delahanty, Douglas L
AU - Domschke, Katharina
AU - Dunlop, Boadie W
AU - Dzubur-Kulenovic, Alma
AU - Evans, Alexandra
AU - Feeny, Norah C
AU - Franz, Carol E
AU - Gautam, Aarti
AU - Geuze, Elbert
AU - Goci, Aferdita
AU - Hammamieh, Rasha
AU - Jakovljevic, Miro
AU - Jett, Marti
AU - Jones, Ian
AU - Kaufman, Milissa L
AU - Kessler, Ronald C
AU - King, Anthony P
AU - Kremen, William S
AU - Lawford, Bruce R
AU - Lebois, Lauren A M
AU - Lewis, Catrin
AU - Liberzon, Israel
AU - Rutten, Bart P F
AU - Schijven, Dick
AU - Vinkers, Christiaan H
N1 - Funding Information:
This work was supported by the National Institute of Mental Health/U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, MBS, KJRe, and KCK]), and National Institutes of Health (Grant No. 5U01MH109539 [to the Psychiatric Genomics Consortium] and Grant No. U19 MH069056 [to BWD])). Financial support for the PTSD PGC was provided by the Cohen Veterans Bioscience, Stanley Center for Psychiatric Research at the Broad Institute, and One Mind. Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience Statistical analyses were carried out on the LISA/Genetic Cluster Computer ( https://userinfo.surfsara.nl/systems/lisa ) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209).
Funding Information:
This work was supported by the National Institute of Mental Health/U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, MBS, KJRe, and KCK]), and National Institutes of Health (Grant No. 5U01MH109539 [to the Psychiatric Genomics Consortium] and Grant No. U19 MH069056 [to BWD])). Financial support for the PTSD PGC was provided by the Cohen Veterans Bioscience, Stanley Center for Psychiatric Research at the Broad Institute, and One Mind. Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience Statistical analyses were carried out on the LISA/Genetic Cluster Computer (https://userinfo.surfsara.nl/systems/lisa) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The views expressed in this article are those of the authors and do not reflect the official policy or position of the DoD, or the U.S. Government. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. We thank the investigators who comprise the PGC-PTSD working group and especially the more than 206,000 research participants worldwide who shared their life experiences and biological samples with PGC-PTSD investigators. We thank Henry R. Kranzler for his critical input.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Posttraumatic stress disorder (PTSD) is a heritable (h
2 = 24-71%) psychiatric illness. Copy number variation (CNV) is a form of rare genetic variation that has been implicated in the etiology of psychiatric disorders, but no large-scale investigation of CNV in PTSD has been performed. We present an association study of CNV burden and PTSD symptoms in a sample of 114,383 participants (13,036 cases and 101,347 controls) of European ancestry. CNVs were called using two calling algorithms and intersected to a consensus set. Quality control was performed to remove strong outlier samples. CNVs were examined for association with PTSD within each cohort using linear or logistic regression analysis adjusted for population structure and CNV quality metrics, then inverse variance weighted meta-analyzed across cohorts. We examined the genome-wide total span of CNVs, enrichment of CNVs within specified gene-sets, and CNVs overlapping individual genes and implicated neurodevelopmental regions. The total distance covered by deletions crossing over known neurodevelopmental CNV regions was significant (beta = 0.029, SE = 0.005, P = 6.3 × 10
-8). The genome-wide neurodevelopmental CNV burden identified explains 0.034% of the variation in PTSD symptoms. The 15q11.2 BP1-BP2 microdeletion region was significantly associated with PTSD (beta = 0.0206, SE = 0.0056, P = 0.0002). No individual significant genes interrupted by CNV were identified. 22 gene pathways related to the function of the nervous system and brain were significant in pathway analysis (FDR q < 0.05), but these associations were not significant once NDD regions were removed. A larger sample size, better detection methods, and annotated resources of CNV are needed to explore this relationship further.
AB - Posttraumatic stress disorder (PTSD) is a heritable (h
2 = 24-71%) psychiatric illness. Copy number variation (CNV) is a form of rare genetic variation that has been implicated in the etiology of psychiatric disorders, but no large-scale investigation of CNV in PTSD has been performed. We present an association study of CNV burden and PTSD symptoms in a sample of 114,383 participants (13,036 cases and 101,347 controls) of European ancestry. CNVs were called using two calling algorithms and intersected to a consensus set. Quality control was performed to remove strong outlier samples. CNVs were examined for association with PTSD within each cohort using linear or logistic regression analysis adjusted for population structure and CNV quality metrics, then inverse variance weighted meta-analyzed across cohorts. We examined the genome-wide total span of CNVs, enrichment of CNVs within specified gene-sets, and CNVs overlapping individual genes and implicated neurodevelopmental regions. The total distance covered by deletions crossing over known neurodevelopmental CNV regions was significant (beta = 0.029, SE = 0.005, P = 6.3 × 10
-8). The genome-wide neurodevelopmental CNV burden identified explains 0.034% of the variation in PTSD symptoms. The 15q11.2 BP1-BP2 microdeletion region was significantly associated with PTSD (beta = 0.0206, SE = 0.0056, P = 0.0002). No individual significant genes interrupted by CNV were identified. 22 gene pathways related to the function of the nervous system and brain were significant in pathway analysis (FDR q < 0.05), but these associations were not significant once NDD regions were removed. A larger sample size, better detection methods, and annotated resources of CNV are needed to explore this relationship further.
UR - http://www.scopus.com/inward/record.url?scp=85138374349&partnerID=8YFLogxK
U2 - 10.1038/s41380-022-01776-4
DO - 10.1038/s41380-022-01776-4
M3 - Article
C2 - 36131047
SN - 1359-4184
VL - 27
SP - 5062
EP - 5069
JO - Molecular Psychiatry
JF - Molecular Psychiatry
IS - 12
ER -